Sunshine Guojian Pharmaceutical (Shanghai) Co (SHSE:688336) Interest Coverage: 4.92 (As of Mar. 2026) — 100% Below Median


SHSE:688336 Sunshine Guojian Pharmaceutical (Shanghai) Co Ltd SHSE:688336
83 GF Score
Price ¥60.72
GF Value ¥66.79
Valuation Fairly Valued
! 3 Warning Signs
View Full Analysis

What is Sunshine Guojian Pharmaceutical (Shanghai) Co Interest Coverage?

Sunshine Guojian Pharmaceutical (Shanghai) Co SHSE:688336 +2.64% 83 Interest Coverage is 4.92 as of Mar. 2026, which is 100% below its 10-year median of 1,084.80. GuruFocus rates SHSE:688336 with a GF Score™ of 83/100 and a GF Value™ of ¥66.79 (Fairly Valued). The stock has 3 warning signs investors should review. Among 377 Biotechnology companies, Sunshine Guojian Pharmaceutical (Shanghai) Co ranks worse than 54.11% on this metric.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income by its Interest Expense. Sunshine Guojian Pharmaceutical (Shanghai) Co's Operating Income for the three months ended in Mar. 2026 was ¥191 Mil. Sunshine Guojian Pharmaceutical (Shanghai) Co's Interest Expense for the three months ended in Mar. 2026 was ¥-39 Mil. Sunshine Guojian Pharmaceutical (Shanghai) Co's interest coverage for the quarter that ended in Mar. 2026 was 4.92. The higher the ratio, the stronger the company's financial strength is.

Good Sign:

Sunshine Guojian Pharmaceutical (Shanghai) Co Ltd has no debt.

The historical rank and industry rank for Sunshine Guojian Pharmaceutical (Shanghai) Co's Interest Coverage or its related term are showing as below:

SHSE:688336' s Interest Coverage Range Over the Past 10 Years
Min: 3.84   Med: 1084.8   Max: No Debt
Current: 64.91

SHSE:688336's Interest Coverage is ranked worse than
54.11% of 377 companies
in the Biotechnology industry
Industry Median: 106.07 vs SHSE:688336: 64.91

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Sunshine Guojian Pharmaceutical (Shanghai) Co  (SHSE:688336) Interest Coverage Explanation

Ben Graham requires that a company has a minimum interest coverage of 5 with the companies he invested. If the interest coverage is less than 2, the company is burdened by debt. Any business slow or recession may drag the company into a situation where it cannot pay the interest on its debt.

Interest Coverage is an important factor when GuruFocus ranks a company's overage Financial Strength .

Sunshine Guojian Pharmaceutical (Shanghai) Co Interest Coverage Related Terms

Sunshine Guojian Pharmaceutical (Shanghai) Co Interest Coverage Historical Data

* Premium members only.

The historical data trend for Sunshine Guojian Pharmaceutical (Shanghai) Co's Interest Coverage can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: For Interest Coverage, "No debt" indicates no long-term debt. An indication of "No Debt" does not necessarily mean that the company has no long-term debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

Sunshine Guojian Pharmaceutical (Shanghai) Co Interest Coverage Chart

Sunshine Guojian Pharmaceutical (Shanghai) Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Interest Coverage
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 3.84 151.17 213.11 5,549.03

Sunshine Guojian Pharmaceutical (Shanghai) Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Interest Coverage Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 344.30 159.62 20.37 No Debt 4.92

SHSE:688336 vs VRTX, REGN, ALNY: Interest Coverage Comparison

For the Biotechnology subindustry, Sunshine Guojian Pharmaceutical (Shanghai) Co's Interest Coverage, along with its competitors' market caps and Interest Coverage data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Sunshine Guojian Pharmaceutical (Shanghai) Co Interest Coverage vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Sunshine Guojian Pharmaceutical (Shanghai) Co's Interest Coverage distribution charts can be found below:

* The bar in red indicates where Sunshine Guojian Pharmaceutical (Shanghai) Co's Interest Coverage falls into.


SHSE:688336
83GF Score
Sunshine Guojian Pharmaceutical (Shanghai) Co Ltd SHSE:688336
Interest Coverage is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Sunshine Guojian Pharmaceutical (Shanghai) Co Interest Coverage Calculation

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense:

If Interest Expense is negative and Operating Income is positive, then

Interest Coverage=-1* Operating Income /Interest Expense

Else if Interest Expense is negative and Operating Income is negative, then

The company did not have earnings to cover the interest expense.

Else if Interest Expense is 0 and Long-Term Debt & Capital Lease Obligation is 0, then

The company had no debt (1).


Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Sunshine Guojian Pharmaceutical (Shanghai) Co's Interest Coverage for the fiscal year that ended in Dec. 2025 is calculated as

Here, for the fiscal year that ended in Dec. 2025, Sunshine Guojian Pharmaceutical (Shanghai) Co's Interest Expense was ¥-1 Mil. Its Operating Income was ¥3,157 Mil. And its Long-Term Debt & Capital Lease Obligation was ¥0 Mil.

Interest Coverage=-1* Operating Income (A: Dec. 2025 )/Interest Expense (A: Dec. 2025 )
=-1*3157.398/-0.569
=5,549.03

Sunshine Guojian Pharmaceutical (Shanghai) Co's Interest Coverage for the quarter that ended in Mar. 2026 is calculated as

Here, for the three months ended in Mar. 2026, Sunshine Guojian Pharmaceutical (Shanghai) Co's Interest Expense was ¥-39 Mil. Its Operating Income was ¥191 Mil. And its Long-Term Debt & Capital Lease Obligation was ¥0 Mil.

Interest Coverage=-1* Operating Income (Q: Mar. 2026 )/Interest Expense (Q: Mar. 2026 )
=-1*191.425/-38.924
=4.92

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The higher the ratio, the stronger the company's Financial Strength is.

Frequently Asked Questions Learn more about Interest Coverage →
What does a Interest Coverage of 4.92 mean?
Sunshine Guojian Pharmaceutical (Shanghai) Co (SHSE:688336) has a Interest Coverage of 4.92 as of Mar. 2026. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on Sunshine Guojian Pharmaceutical (Shanghai) Co and its competitors. This is 100% below median its historical median of 1,084.80. Over the past decade, Sunshine Guojian Pharmaceutical (Shanghai) Co's Interest Coverage has ranged from 3.84 to 10,000.00. According to the industry distribution chart, Sunshine Guojian Pharmaceutical (Shanghai) Co ranks #204 out of 377 companies in the Biotechnology industry, placing it in the top 54.1%.
Is Sunshine Guojian Pharmaceutical (Shanghai) Co's Interest Coverage too high?
Sunshine Guojian Pharmaceutical (Shanghai) Co's current Interest Coverage of 4.92 is 100% below median its 10-year median of 1,084.80. Over the past 10 years, this metric has ranged from a low of 3.84 to a high of 10,000.00. The Biotechnology industry median Interest Coverage is 106.07. Sunshine Guojian Pharmaceutical (Shanghai) Co's value of 4.92 is 95.4% below this industry median. Based on the distribution chart, Sunshine Guojian Pharmaceutical (Shanghai) Co ranks #204 out of 377 companies in the Biotechnology industry, which is below the industry midpoint. Overall, Sunshine Guojian Pharmaceutical (Shanghai) Co has a GF Score™ of 83/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Sunshine Guojian Pharmaceutical (Shanghai) Co's Interest Coverage compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Sunshine Guojian Pharmaceutical (Shanghai) Co ranks #204 out of 377 companies for Interest Coverage. This places Sunshine Guojian Pharmaceutical (Shanghai) Co in the lower half of its industry. The industry median Interest Coverage is 106.07. Sunshine Guojian Pharmaceutical (Shanghai) Co's value of 4.92 is 95.4% below this benchmark. Historically, Sunshine Guojian Pharmaceutical (Shanghai) Co's own Interest Coverage has ranged from 3.84 to 10,000.00 over the past decade. While the company's 10-year median is 1,084.80 vs. the industry median of 106.07, Sunshine Guojian Pharmaceutical (Shanghai) Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Interest Coverage for a Biotechnology company?
The median Interest Coverage among Biotechnology companies is 106.07, based on 377 companies in the industry. Companies in the top quartile (top 25%) have a Interest Coverage significantly above this median, while those in the bottom quartile fall well below. However, Interest Coverage should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Sunshine Guojian Pharmaceutical (Shanghai) Co's current Interest Coverage of 4.92 is 95.4% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Interest Coverage mean?
A high Interest Coverage can signal that a stock is expensive relative to its fundamentals. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on Sunshine Guojian Pharmaceutical (Shanghai) Co and its competitors. For the Biotechnology industry, the median Interest Coverage is 106.07 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Sunshine Guojian Pharmaceutical (Shanghai) Co's current Interest Coverage is 4.92, which is 100% below median its own 10-year median of 1,084.80. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sunshine Guojian Pharmaceutical (Shanghai) Co stock overvalued right now?
Based on GuruFocus' analysis, Sunshine Guojian Pharmaceutical (Shanghai) Co (SHSE:688336) is currently considered Fairly Valued. The stock's GF Value™ is ¥66.79, compared to a current price of ¥60.72 — trading 9.1% below its estimated fair value. The current Interest Coverage is 4.92, which is 100% below median its 10-year median of 1,084.80 and 95.4% below the Biotechnology industry median of 106.07. Sunshine Guojian Pharmaceutical (Shanghai) Co's overall GF Score™ is 83/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Interest Coverage calculated?
Interest Coverage is calculated from a company's financial statements. For Sunshine Guojian Pharmaceutical (Shanghai) Co (SHSE:688336), the current Interest Coverage is 4.92 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Sunshine Guojian Pharmaceutical (Shanghai) Co (SHSE:688336) Overvalued in 2026?

Based on GuruFocus' analysis, Sunshine Guojian Pharmaceutical (Shanghai) Co stock appears to be undervalued. The current stock price of ¥60.72 is trading 9.1% below its estimated GF Value™ of ¥66.79. GuruFocus considers Sunshine Guojian Pharmaceutical (Shanghai) Co to be Fairly Valued.

Key valuation signals for SHSE:688336:

  • Interest Coverage: 4.92 (100% below median its 10-year median of 1,084.80)
  • GF Value™: ¥66.79 vs. price of ¥60.72 (9.1% below fair value)
  • GF Score™: 83/100 with 3 warning signs
  • Industry Position: 95.4% below the Biotechnology median (#204 of 377)

No single metric tells the full story. See the SHSE:688336 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Sunshine Guojian Pharmaceutical (Shanghai) Co Business Description

Address No.399 Libing Road, China (Shanghai) Pilot Free Trade Zone, Shanghai, CHN, 201203
Sunshine Guojian Pharmaceutical (Shanghai) Co Ltd is a biopharmaceutical company providing safe and effective clinical solutions for the treatment of major diseases such as autoimmune diseases and tumors. The company engages in in research and development, manufacturing and commercialization of therapeutic antibody drugs in China. Its products portfolio includes YISAIPU and Xenopax. Its products in pipeline include 302H, 304R, 602, 601A, 609A and 301S.
83GF Score

Get the complete analysis for SHSE:688336

Interest Coverage is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥60.72
Price
¥66.79
GF Value